Approval of the Comsolidated and Stanalone unaudited financial results for the half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shivam Chemicals reported consolidated revenue from operations of ₹13,166.78 lakhs for H1FY26 (ended Sep 30, 2025), up about 39% from ₹9,441.57 lakhs in the same period last year. Total revenue stood at ₹13,257.70 lakhs versus ₹9,517.84 lakhs earlier. Profit before tax rose to ₹252.55 lakhs from ₹87.78 lakhs (nearly 2.9x), and profit after tax jumped to ₹196.51 lakhs from ₹58.02 lakhs (around 3.4x), translating to EPS of ₹1.16 versus ₹0.34. Standalone numbers also showed strong growth, with revenue up about 46% to ₹12,486.95 lakhs and PAT rising to ₹154.60 lakhs from ₹87.82 lakhs. The statutory auditor PSRD & Co. issued an unmodified review report on both sets of results.
Strong top-line and bottom-line growth on a year-on-year basis is a positive signal for shareholders, reflecting improved demand and operating leverage. The PAT growth of over 200% far exceeds the revenue growth, indicating meaningful margin expansion. However, short-term borrowings have nearly doubled, and standalone operating cash flow remains negative, which are points worth watching.